Oryzon Genomics S.A. ORYZF
3.10 USD 0.00 0.00%
At close · Nov 2
- Open
- 3.45
- Prev close
- 3.10
- Mkt cap
- 253.86M
- Vol
- 100
- Avg vol
- 709
- EPS
- -0.03
- P/E
- 0.00
More statistics
- Low
- 3.45
- High
- 3.45
MAX chart
Chart tools
Chart is warming up
The all-time price history for ORYZF has not been loaded yet. Try again in a moment.
Altman Z-Score
6.24 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
P/E -81.7×
P/S 0.0×
P/B 2.0×
P/FCF -88.1×
EV/EBITDA -31.2×
EV/Sales 0.0×
FCF Yield -1.1%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -2.5%
ROIC -2.2%
ROA -1.8%
Revenue -100.0%
Operating Income -45.1%
EPS (diluted) 38.2%
Free Cash Flow 82.0%
Current Ratio 1.9×
Quick Ratio 1.9×
Debt / Equity 0.1×
Net Debt / EBITDA 2.6×
Interest Coverage -10.6×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31